| |
Number of patients
|
|---|
|
Median age, year (range)
|
60 (46–81)
|
|
Gender (%)
|
|
Male
|
51 (85%)
|
|
Female
|
9 (15%)
|
|
Tumor location (%)
|
|
Upper
|
8 (13.3%)
|
|
Middle
|
44 (73.4%)
|
|
Lower
|
5 (8.3%)
|
|
Mutiple
|
3 (5%)
|
|
Clinical stage (%)
|
|
IA
|
1 (1.7%)
|
|
IB
|
3 (5%)
|
|
IIA
|
1 (1.7%)
|
|
IIB
|
23 (38.3%)
|
|
IIIA
|
20 (33.3%)
|
|
IIIB
|
5 (8.3%)
|
|
IIIC
|
7 (11.7%)
|
|
Pathological stage (%)
|
|
IA
|
2 (3.3%)
|
|
IB
|
7 (11.7%)
|
|
IIA
|
1 (1.7%)
|
|
IIB
|
13 (21.7%)
|
|
IIIA
|
12 (20.0%)
|
|
IIIB
|
10 (16.7%)
|
|
IIIC
|
10 (16.7%)
|
|
PCR
|
5 (8.3%)
|
|
Histologic grade (%)
|
|
G1
|
8 (13.3%)
|
|
G2
|
34 (56.7%)
|
|
G3
|
17 (28.3%)
|
|
G4
|
1 (1.7%)
|
|
Operation approach (%)
|
|
Thoracotomy
|
25 (41.7%)
|
|
VATS
|
35 (58.3%)
|
|
Neoadjuvant
|
|
No
|
46 (76.7%)
|
|
CRT
|
11 (18.3%)
|
|
CT
|
3 (5%)
|
|
Intraoperative RLN injury (%)
|
|
Yes
|
24 (40%)
|
|
No
|
36 (60%)
|
- Abbreviations: CRT Chemoradiotherapy, CT Computed tomography, PCR Pathologic complete response, RLN Recurrent laryngeal nerve, VATS Video-assisted thoracic surgery
